Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Biomaterial 29, 215227
Injections bypass the damaged area and deliver B12 into the bloodstream
The agreement marks the second such collaboration by the company with a biopharma giant: In February, Immuneering announced a clinical trial agreement with Regeneron Pharmaceuticals (NASDAQ: REGN) to evaluate atebimetinib in combination with the anti-PD-1 therapy Libtayo (cemiplimab) in patients with advanced non-small cell lung cancer
E., Hadigan, C
US$ 29.36
US$ 24.00
US$ 28.96
US$ 29.75
US$ 25.20
US$ 25.41
US$ 27.26
